kr
88. 15
+1.15
+1.3218%
kr
2.97B Market Cap
64.85 P/E Ratio
0.49% Div Yield
115,470 Volume
3.48 Eps
kr 87
Previous Close Want to track VITR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
VITR closed Monday higher at kr88.15, an increase of 1.3218% from Friday's close, completing a monthly decrease of -16.2072% or -kr17.05. Over the past 12 months, VITR stock lost -35.6569%.
VITR pays dividends to its shareholders, with the most recent payment made on May 12, 2026. The next estimated payment will be in In 9 months on May 12, 2027 for a total of kr1.1.
The last earnings report, released on Apr 22, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.1023%, based on the last three reports.
Vitrolife AB has completed 1 stock splits, with the recent split occurring on May 17, 2018.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on LSE (SEK).
Vitrolife AB (VITR) FAQ
What is the stock price today?
The current price is kr88.15.
On which exchange is it traded?
Vitrolife AB is listed on XSTO.
What is its stock symbol?
The ticker symbol is VITR.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.49%.
What is its market cap?
As of today, the market cap is 2.97B.
Has Vitrolife AB ever had a stock split?
Vitrolife AB had 1 splits and the recent split was on May 17, 2018.
Vitrolife AB Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Bronwyn Brophy O'Connor CEO | XSTO Exchange | SE0011205202 ISIN |
| SE Country | 1,150 Employees | 6 May 2026 Last Dividend | 17 May 2018 Last Split | - IPO Date |
Overview
Vitrolife AB (publ) is a pioneering company specializing in offering innovative products and solutions for assisted reproduction. The company's diverse portfolio is designed to support various aspects of the in vitro fertilization (IVF) process, from sperm processing to embryo transfer and cryopreservation. Established in 1994, Vitrolife has its headquarters in Gothenburg, Sweden. Over the years, it has expanded its presence across the globe, operating in regions such as Europe, the Middle East, India, Africa, Asia, Japan, the Pacific, and the Americas, underscoring its commitment to aiding fertility clinics and patients worldwide.
Products and Services
Vitrolife AB (publ) offers a comprehensive range of products and technologies designed to enhance the efficiency and success rates of assisted reproductive treatments. Below is an overview of their key offerings:
- Sperm Processing - Products aimed at optimizing the preparation of sperm for IVF procedures, ensuring the selection of the highest quality sperm for insemination.
- Oocyte Retrieval Needles - Specialized needles designed for the safe and effective retrieval of oocytes from the ovaries during IVF treatments.
- Micromanipulation Pipettes - Precision tools used for intricate procedures such as intracytoplasmic sperm injection (ICSI), crucial for handling and manipulating gametes and embryos at microscopic levels.
- Time-Lapse Systems - Innovations like the EmbryoScope allow for continuous monitoring of embryo development, providing invaluable insights for selecting the best embryo for transfer.
- Laser and Imaging Systems - Advanced equipment that aids in embryo biopsy and assessment, enhancing precision and outcomes in preimplantation genetic testing (PGT).
- IVF Media and Oil - High-quality culture mediums and oils that create an optimal environment for embryo cultivation and development outside the human body.
- Embryo Transfer - Devices and tools specifically designed to facilitate the gentle and precise transfer of embryos into the uterus, maximizing the chances of successful implantation.
- Cryopreservation - Solutions for the freezing and thawing of eggs, sperm, and embryos, allowing for their preservation for future use in fertility treatments.
- Genomics Kits - Advanced testing kits that provide genetic screening of embryos, helping in the selection of embryos with the best potential outcomes.
- Evaluation Tools for Time-Lapse Systems - Software and other tools that assist in interpreting the data captured by time-lapse systems, enabling a deeper understanding of embryo development patterns.
Contact Information
Address: Gustaf Werners gata 2
Phone: 46 3 17 21 80 00
Website: https://www.vitrolife.com
